Revenue, last quarter
$9.6M
+0.2% vs same quarter last year
Net income
−$4.4M
−326.9% vs same quarter last year
EPS, diluted
−$0.07
−333.3% vs same quarter last year
Operating cash flow
−$583K
+61.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $37.1M | −$8.2M |
| FY24 | $35.6M | −$20.7M |
| FY23 | $31.1M | −$29.2M |
| FY22 | $34.7M | −$32.8M |
| FY21 | $43.2M | −$24.6M |
| FY20 | $41M | −$7.8M |
| FY19 | $24.9M | −$19.3M |
| FY18 | $22.5M | −$17.2M |
| FY17 | $15.2M | −$8.5M |
| FY16 | $9.5M | −$11.8M |
| FY15 | $4.8M | −$9.5M |
| FY14 | $4.1M | −$9.3M |
| FY13 | $2.4M | −$4.7M |
| FY12 | $1.3M | −$3.7M |
| FY11 | $36.1K | −$5.5M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 71.5% | −39.8% | −22.1% |
| FY24 | 69.9% | −46.2% | −58.2% |
| FY23 | 70.6% | −102.8% | −94.1% |
| FY22 | 59.8% | −90.9% | −94.6% |
| FY21 | 74.4% | −52.7% | −56.9% |
| FY20 | 73% | −25.3% | −19.1% |
| FY19 | 70.5% | −76% | −77.2% |
| FY18 | 66.7% | −69.3% | −76.5% |
| FY17 | 63.6% | −65% | −55.8% |
| FY16 | 58.5% | −120.6% | −123.5% |
| FY15 | 53.8% | −194.2% | −197.8% |
| FY14 | 48.2% | −167.2% | −226.1% |
| FY13 | 21.1% | −194.5% | −193.1% |
| FY12 | 76.2% | −259.9% | −272.8% |
| FY11 | 67.4% | −12297.7% | −15193.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$12.5M |
| FY24 | −$14.7M |
| FY23 | −$22.2M |
| FY22 | −$34.3M |
| FY21 | −$17.6M |
| FY20 | −$6.3M |
| FY19 | −$17.5M |
| FY18 | −$11.5M |
| FY17 | −$7.5M |
| FY16 | −$6.9M |
| FY15 | −$9.5M |
| FY14 | −$6.8M |
| FY13 | −$3.5M |
| FY12 | −$3.6M |
| FY11 | −$3.9M |
- Cytosorbents
- Healthcare median
Show the numbers
| Year | Cytosorbents | Healthcare median |
|---|---|---|
| FY25 | −22.1% | −30.6% |
| FY24 | −58.2% | −47% |
| FY23 | −94.1% | −58% |
| FY22 | −94.6% | −80.4% |
| FY21 | −56.9% | −71.8% |
| FY20 | −19.1% | −62.2% |
| FY19 | −77.2% | −46.2% |
| FY18 | −76.5% | −49.6% |
| FY17 | −55.8% | −45.9% |
| FY16 | −123.5% | −36% |
| FY15 | −197.8% | −37.8% |
| FY14 | −226.1% | −35.5% |
| FY13 | −193.1% | −37.1% |
| FY12 | −272.8% | −29.1% |
| FY11 | −15193.9% | −27.9% |